These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 7190412)

  • 1. [The influence of clofibrate on elevated serum lactate levels in diabetic patients treated with biguanides (author's transl)].
    Vogelberg KH; Cicmir I; Heggen ME
    Arzneimittelforschung; 1980; 30(4):683-5. PubMed ID: 7190412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum concentration of lactate in diabetic patients treated with biguanides in relationship to renal function (author's transl)].
    Sailer D; Ganawal S; Berg G
    Med Klin; 1979 Mar; 74(9):318-24. PubMed ID: 423858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Semi-automatic determination of blood lactate during hypoglycemic treatment with biguanides].
    Gelo Signorino R; Castellazzi R; Gamba S; Grassi G; Zanno C; Bruni B
    Ann Osp Maria Vittoria Torino; 1979; 22(1-6):18-37. PubMed ID: 122229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood lactate and biguanide therapy: comparison between phenformin, metformin and buformin in 408 senile diabetics].
    Bruneder H; Klein HJ
    Acta Med Austriaca; 1978; 5(3):88-90. PubMed ID: 752220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood lactate and pyruvate levels in diabetic patient treated with sulphonylureas with and without biguanides.
    Sitprija S; Vajanamarhutue C; Bunnag S
    J Med Assoc Thai; 1982 Feb; 65(2):63-71. PubMed ID: 7077214
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of primary hyperlipoproteinemia type IIb and IV. Comparison of the lipid lowering effect of phenformin, clofibrate, and a combination of both (author's transl)].
    Koschinsky T; Lenhard P; Gries FA; Vogelberg KH; Wolfram G; Lang PD; Vollmar J
    Med Klin; 1977 Sep; 72(38):1537-43. PubMed ID: 904549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biguanide-induced and - associated lactic acidosis: serum and tissue biguanide levels in hyperlactaemia and lactic acidosis (author's transl)].
    Irsigler K; Kritz H; Regal H; Kaspar L
    Wien Klin Wochenschr; 1979 Jan; 91(2):59-65. PubMed ID: 433281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of biguanide therapy on lactate metabolism during graded submaximal ergometric testing].
    Pilger E; Schmid P; Goebel R
    Acta Med Austriaca; 1978; 5(3):91-5. PubMed ID: 752221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)].
    Koschinsky T; Gries FA; Schwandt P; Weisweiler P; Hansen W; Nijssen J; Beckmann R
    MMW Munch Med Wochenschr; 1977 May; 119(20):701-4. PubMed ID: 195201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The risk of lacticate acidosis: a comparison of the 3 biguanides in treatment of diabetics (authors' transl)].
    Irsigler K; Kritz H; Regal H; Foltin E
    Wien Klin Wochenschr; 1978 May; 90(10):332-7. PubMed ID: 654296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of clofibrate on glucose metabolism in diabetes mellitus without endogenous hypertriglyceridemia (author's transl)].
    Vogelberg KH; Scherff R; Schulze-Schleppinghoff B
    Arzneimittelforschung; 1982; 32(4):413-6. PubMed ID: 7049189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Haemodialysis in the treatment of biguanide-induced lactate acidosis (author's transl)].
    Althoff PH; Fassbinder W; Neubauer M; Koch KM; Schöffling K
    Dtsch Med Wochenschr; 1978 Jan; 103(2):61-8. PubMed ID: 627171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of biguanids on the lactate metabolism. Studies in diabetics under submaximal ergometric exercise (author's transl)].
    Pilger E; Schmid P; Goebel R
    Med Klin; 1979 Jun; 74(22):859-65. PubMed ID: 470783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination of clofibrate and phenformin in the treatment of endogenous hypertriglyceridaemia (author's transl)].
    Vogelberg KH
    Dtsch Med Wochenschr; 1976 Dec; 101(51):1868-71. PubMed ID: 1001205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood lactate and pyruvate levels in diabetic patients treated with biguanides with and without sulphonylureas.
    Waters AK; Morgan DB; Wales JK
    Diabetologia; 1978 Feb; 14(2):95-8. PubMed ID: 631461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Behavior of lactate and pyruvate in diabetics during ambulatory treatment with biguanides or with a combination of biguanides and sulfonylureas. II].
    Lunetta M; Presti C; Mughini MT; Mughini L
    Clin Ter; 1980 Jun; 93(6):657-72. PubMed ID: 6775864
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the clinical use of biguanides].
    Haese E
    Arzneimittelforschung; 1969 Apr; 19(4):633-8. PubMed ID: 5819164
    [No Abstract]   [Full Text] [Related]  

  • 18. Biguanides. Mode of action and role in the up-to-date treatment of diabetes mellitus.
    Fövényi J
    Ther Hung; 1971; 19(2):43-8. PubMed ID: 5172874
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood lactate levels in diabetics on different modes of therapy.
    Viswanathan M; Snehalatha C; Ramachandran A; Viswanathan M
    J Assoc Physicians India; 1979 Aug; 27(8):735-9. PubMed ID: 120366
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biguanides: reasons for withdrawal of drugs and remaining indications].
    Bolzano K
    Acta Med Austriaca; 1978; 5(3):85-8. PubMed ID: 752219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.